Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Ovid Therapeutics (NASDAQ: OVID) surges 28% on $175m private placement: What does it mean for biotech investors? Ovid Therapeutics (NASDAQ: OVID) jumped 28% after securing $175M via a PIPE deal. Explore its pipeline focus, stock sentiment, and investor outlook. byPallavi MadhirajuOctober 3, 2025